国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

囯产极品美女高潮无套久久久 | 国产精品久久久久久人妻| 男人j进女人p免费视频| gogogo日本免费观看| 99精品人妻少妇一区二区| 精品久久久无码中文字幕 | 成人奭片免费观看| 男女啪啪久久精品亚洲A| 国产精品自在线拍国产| 久久久久亚洲AV成人人电影| 妻子6免费完整版电影| 日本人妻丰满熟妇久久久久久| 国产最好看的级SUV卡毛| 亚洲av中文无码乱人伦在线播放| 鸡毛飞上天电视剧全集观看免费| 精品无码亚洲一区二区三区毛| 亚洲色精品三区二区一区| 波多野结衣人妻厨房大战| 国产精品久久久久久吹潮| 国产激情久久久久影院老熟女| 天天影视色香欲综合久久| 黑人巨大精品欧美一区二区 | 亚洲av无码成人精品区| 色AV色婷婷66人妻久久久| 亚洲精品在线| 老熟妇高潮一区二区三区| 人妻无码熟妇乱又伦精品 | 全黄裸片一29分钟免费真人版| 浴室人妻的情欲hd三级 | 成人综合伊人五月婷久久| 天堂资源中文最新版在线一区| 国产精品色情国产三级在| 少女动漫在线高清免费观看 | 欧美肥胖老太玩黑人| 无人在线完整免费高清观看| 亚洲精品色情app在线下载观看 | 免费无遮挡无码永久视频| 精品欧洲av无码一区二区| 无码日韩精品一区二区人妻| 国产精品原创巨作av| 青春草无码精品视频在线观看 |